Revealed: drug firms funding UK patient groups that lobby for NHS approval of medicines

Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticalsDrug companies are systematically funding grassroots patient groups that lobby the NHS medicines watchdog to approve the rollout of their drugs, theObservercan reveal.An investigation by the Observer has found that of 173 drug appraisals conducted by theNational Institute for Health and Care Excellence (Nice) since April 2021, 138 involved patient groups that had a financial link to the maker of the drug being assessed, or have since received funding.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Drugs Science Health Society National Institute for Health and Care Excellence Politics NHS Pharmaceuticals industry UK news Source Type: news